Dr. Safwan A. Saker, MD

Dr. Saker practices at DMC Harper University Hospital in Detroit, Michigan, part of Tenet Healthcare.

Dr. Saker's NPI, 1417941477, was assigned on September 7, 2005. Dr. Saker holds Michigan license 4301063663.

Dr. Saker's primary practice is DMC Harper University Hospital, at 3990 John R Street, Detroit, MI 48201 in Wayne County. The practice phone is (313) 745-6211.

Dr. Saker's primary practice is DMC Harper University Hospital in Detroit, Michigan, part of Tenet Healthcare. Dr. Saker is also affiliated with DMC Detroit Receiving Hospital. The medical group on file is Wayne Health. Dmand AI also links Dr. Saker to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saker practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Saker's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Saker is licensed in Michigan.

CMS data shows 1,047 Medicare services from Dr. Saker across 6 procedure codes in 2024, for 238 Medicare patients. Medicare paid $79,343 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 238 Medicare patients who saw Dr. Saker in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saker's median patient age at 61, with 53% women.

In 2024, Dr. Saker wrote 163 Medicare Part D claims for 71 patients. 85% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $56 in total drug cost. In 2022, CMS named 55 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Saker for performance year 2024, reported as part of a group. Dr. Saker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Saker from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $216.